Pharmacology News

A post-hoc analysis of the Twirla contraceptive patch showed that it was well tolerated among women with a BMI of 25 to 30 kg/m2 as well as those with a BMI less than 25 kg/m2, according to researchers.

Medications that lower BP reduced CV event rates regardless of prior CVD or baseline BP, according to a meta-analysis published in The Lancet.

Marginalization and stigma are directly related to poor physical and mental health outcomes, according to a speaker at the ACP Internal Medicine Meeting, held virtually.

Ondansetron exposure during pregnancy was not associated with an increased risk for fetal death or major congenital malformations compared with other antiemetics, according to results of a large, multinational cohort study and meta-analysis.

HHS has released new practice guidelines to expand access to buprenorphine for opioid use disorder.

Nearly one-third of patients with atrial fibrillation and/or venous thromboembolism treated with a direct oral anticoagulant, or DOAC, were also using aspirin without clear indications, researchers reported.

Patients who have public insurance had a greater risk for persistent opioid use after a dental procedure compared with patients who have private insurance, a retrospective cohort study found.

Black, Asian and female patients with type 2 diabetes are less likely to receive a prescription for an SGLT2 inhibitor compared with other groups, even when diagnosed with cardiovascular or kidney disease, a database analysis shows.

The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal polyps or chronic idiopathic urticaria, according to the manufacturers.

Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.